Cervical Screening Programme, England - 2022-2023 [NS]

Call & recall

In 2022-2023

Coverage for ages 25 to 64 years was 68.7%
 

Cervical screening

In 2022-2023:

3.48 million samples were tested.
(all ages)

Colposcopy

In 2022-2023:

246,762 individuals were referred for colposcopy
(all ages)

This publication presents information about the NHS Cervical Screening Programme (‘the programme’) in England in the year 2022-2023.

Individuals between the ages of 25* and 64 are invited for regular cervical screening under the programme, the intent of which is to detect abnormalities within the cervix that could, if undetected and untreated, develop into cervical cancer.  Individuals outside of this age group may also be assessed by the programme if they require follow-up testing after previous abnormal screening, or if they had not had an adequate test since their 60th birthday.

The statistics presented cover the following topic areas in the cervical screening programme:

• Call and recall
• Cervical sample testing
• Colposcopy

The associated data tables, interactive visualisation, appendices and quality statement are available on the main publication page:

https://digital.nhs.uk/pubs/cervical2022

*Invitations are first sent at age 24.5 years.

Report bulletin (this document)

• Presents a detailed summary of the findings from the 2022-2023 data collection.
• Further information on the data presented within this report is available in the additional publication resources outlined here.

Interactive dashboard

• The main report is accompanied by an interactive data dashboard. Data are presented in maps and charts. This allows comparison between areas as well as showing changes over time.
• The geographic breakdowns included in the dashboard are upper tier local authority, region and country.

http://bit.ly/Cervical_Stats_Dashboard

Data tables

• Contain all relevant statistics for 2022-2023.
• Available in Excel and csv formats.

Appendices

Further detail on topics including:

• Publication context
• Coverage definitions
• Changes to the programme
• Data collection

Quality statement:

• Contextual information to aid understanding and presentation of the data including the methods used to compile the statistics and other background information that users may find useful.
• All resources are available from the publication page. 

Human Papilloma Virus (HPV) primary screening was fully implemented in December 2019¹. With HPV primary screening, a sample is first tested for high risk types of HPV (hrHPV) associated with the development of cervical cancer. Where the test result is positive, a cytology assessment is then performed on the same sample. See appendix J for further details.

¹ https://phescreening.blog.gov.uk/2020/01/23/significant-landmark-as-primary-hpv-screening-is-offered-across-england/